Cargando…

Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy

In cancer combination therapy, a multimodal delivery vector is used to improve the bioavailability of multiple anti-cancer hydrophobic drugs. Further, targeted delivery of therapeutics along with simultaneous monitoring of the drug release at the tumor site without normal organ toxicity is an emergi...

Descripción completa

Detalles Bibliográficos
Autores principales: Laskar, Partha, Dhasmana, Anupam, Kotnala, Sudhir, Jaggi, Meena, Yallapu, Murali M., Chauhan, Subhash C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222396/
https://www.ncbi.nlm.nih.gov/pubmed/37242568
http://dx.doi.org/10.3390/pharmaceutics15051326
_version_ 1785049688155619328
author Laskar, Partha
Dhasmana, Anupam
Kotnala, Sudhir
Jaggi, Meena
Yallapu, Murali M.
Chauhan, Subhash C.
author_facet Laskar, Partha
Dhasmana, Anupam
Kotnala, Sudhir
Jaggi, Meena
Yallapu, Murali M.
Chauhan, Subhash C.
author_sort Laskar, Partha
collection PubMed
description In cancer combination therapy, a multimodal delivery vector is used to improve the bioavailability of multiple anti-cancer hydrophobic drugs. Further, targeted delivery of therapeutics along with simultaneous monitoring of the drug release at the tumor site without normal organ toxicity is an emerging and effective strategy for cancer treatment. However, the lack of a smart nano-delivery system limits the application of this therapeutic strategy. To overcome this issue, a PEGylated dual drug, conjugated amphiphilic polymer (CPT-S-S-PEG-CUR), has been successfully synthesized by conjugating two hydrophobic fluorescent anti-cancer drugs, curcumin (CUR) and camptothecin (CPT), through an ester and a redox-sensitive disulfide (-S-S-) linkage, respectively, with a PEG chain via in situ two-step reactions. CPT-S-S-PEG-CUR is spontaneously self-assembled in the presence of tannic acid (TA, a physical crosslinker) into anionic, comparatively smaller-sized (~100 nm), stable nano-assemblies in water in comparison to only polymer due to stronger H-bond formation between polymer and TA. Further, due to the spectral overlap between CPT and CUR and a stable, smaller nano-assembly formation by the pro-drug polymer in water in presence of TA, a successful Fluorescence Resonance Energy Transfer (FRET) signal was generated between the conjugated CPT (FRET donor) and conjugated CUR (FRET acceptor). Interestingly, these stable nano-assemblies showed a preferential breakdown and release of CPT in a tumor-relevant redox environment (in the presence of 50 mM glutathione), leading to the disappearance of the FRET signal. These nano-assemblies exhibited a successful cellular uptake by the cancer cells and an enhanced antiproliferative effect in comparison to the individual drugs in cancer cells (AsPC1 and SW480). Such promising in vitro results with a novel redox-responsive, dual-drug conjugated, FRET pair-based nanosized multimodal delivery vector can be highly useful as an advanced theranostic system towards effective cancer treatment.
format Online
Article
Text
id pubmed-10222396
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102223962023-05-28 Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy Laskar, Partha Dhasmana, Anupam Kotnala, Sudhir Jaggi, Meena Yallapu, Murali M. Chauhan, Subhash C. Pharmaceutics Article In cancer combination therapy, a multimodal delivery vector is used to improve the bioavailability of multiple anti-cancer hydrophobic drugs. Further, targeted delivery of therapeutics along with simultaneous monitoring of the drug release at the tumor site without normal organ toxicity is an emerging and effective strategy for cancer treatment. However, the lack of a smart nano-delivery system limits the application of this therapeutic strategy. To overcome this issue, a PEGylated dual drug, conjugated amphiphilic polymer (CPT-S-S-PEG-CUR), has been successfully synthesized by conjugating two hydrophobic fluorescent anti-cancer drugs, curcumin (CUR) and camptothecin (CPT), through an ester and a redox-sensitive disulfide (-S-S-) linkage, respectively, with a PEG chain via in situ two-step reactions. CPT-S-S-PEG-CUR is spontaneously self-assembled in the presence of tannic acid (TA, a physical crosslinker) into anionic, comparatively smaller-sized (~100 nm), stable nano-assemblies in water in comparison to only polymer due to stronger H-bond formation between polymer and TA. Further, due to the spectral overlap between CPT and CUR and a stable, smaller nano-assembly formation by the pro-drug polymer in water in presence of TA, a successful Fluorescence Resonance Energy Transfer (FRET) signal was generated between the conjugated CPT (FRET donor) and conjugated CUR (FRET acceptor). Interestingly, these stable nano-assemblies showed a preferential breakdown and release of CPT in a tumor-relevant redox environment (in the presence of 50 mM glutathione), leading to the disappearance of the FRET signal. These nano-assemblies exhibited a successful cellular uptake by the cancer cells and an enhanced antiproliferative effect in comparison to the individual drugs in cancer cells (AsPC1 and SW480). Such promising in vitro results with a novel redox-responsive, dual-drug conjugated, FRET pair-based nanosized multimodal delivery vector can be highly useful as an advanced theranostic system towards effective cancer treatment. MDPI 2023-04-24 /pmc/articles/PMC10222396/ /pubmed/37242568 http://dx.doi.org/10.3390/pharmaceutics15051326 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Laskar, Partha
Dhasmana, Anupam
Kotnala, Sudhir
Jaggi, Meena
Yallapu, Murali M.
Chauhan, Subhash C.
Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy
title Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy
title_full Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy
title_fullStr Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy
title_full_unstemmed Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy
title_short Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy
title_sort glutathione-responsive tannic acid-assisted fret nanomedicine for cancer therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222396/
https://www.ncbi.nlm.nih.gov/pubmed/37242568
http://dx.doi.org/10.3390/pharmaceutics15051326
work_keys_str_mv AT laskarpartha glutathioneresponsivetannicacidassistedfretnanomedicineforcancertherapy
AT dhasmanaanupam glutathioneresponsivetannicacidassistedfretnanomedicineforcancertherapy
AT kotnalasudhir glutathioneresponsivetannicacidassistedfretnanomedicineforcancertherapy
AT jaggimeena glutathioneresponsivetannicacidassistedfretnanomedicineforcancertherapy
AT yallapumuralim glutathioneresponsivetannicacidassistedfretnanomedicineforcancertherapy
AT chauhansubhashc glutathioneresponsivetannicacidassistedfretnanomedicineforcancertherapy